Join
Live feed
·
INSIDERFilingvia Quantisnow
Crinetics Pharmaceuticals Inc. logo

Chief Med and Dev Officer Pizzuti Dana exercised 17,500 shares at a strike of $17.28 and sold $781,350 worth of shares (15,000 units at $52.09), increasing direct ownership by 9% to 31,748 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRNX (Crinetics Pharmaceuticals Inc.) and more on Quantisnow.